EQA 2025 - Serum Protein Electrophoresis (EPS) |
---|
Expert Biologists - Scheme Coordinators:
Magali DECHOMET, Béatrice GUILLEMIN and Christine LOMBARD EQA performed since 2012
Number of participating laboratories in 2024: 418 |
1 - Scheme Overview
This external quality assessment scheme provides normal and disease-related electrophoretic profiles for assessing monoclonal gammopathy (paraproteinemia) diagnosis and type determination.
The reports include statistical processing of quantitative results and the analysis of qualitative results: interpretation of electrophoresis, immunofixation and immunotyping performed to identify a monoclonal band detected by electrophoresis.
Participating labs can choose to be assessed for all the analytes of this scheme, or simply a subset of analytes of interest.
2 - Assessment Frequency
Number of surveys per year: 8
Number of control samples per survey: 1
Number of samples per year: 8
3 - List of Analytes Assessed
4 - Description of the Control Samples
Lyophilized human control serums (samples to be resuspended in 1 mL of distilled water).
5 - Clinical Cases
Clinical cases are provided with each investigation.
| Confidentiality Policy | General Terms of Sale | | Last updated : 09/09/2024 | Copyright © 2011-2024 ProBioQual All rights reserved. |